Cara Therapeutics
CARA
$0.70
Share price
4.23%
Change (1 day)
-82.50%
Change (1 year)
Categories
Cara Therapeutics (CARA) - Total assets
Total assets on the balance sheet as of December 2023 : $0.12 B
According to Cara Therapeutics 's latest financial reports the company's total assets are $0.12 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Cara Therapeutics - Total assets on balance sheet (from 2012 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.12 B | -30.94% |
| 2022-12-31 | $0.18 B | -26.24% |
| 2021-12-31 | $0.24 B | -8.89% |
| 2020-12-31 | $0.27 B | 16.4% |
| 2019-12-31 | $0.23 B | 22.08% |
| 2018-12-31 | $0.19 B | 96.72% |
| 2017-12-31 | $97 M | 51.98% |
| 2016-12-31 | $63.82 M | -42.44% |
| 2015-12-31 | $0.11 B | 98.26% |
| 2014-12-31 | $55.93 M | 209.32% |
| 2013-12-31 | $18.08 M | 226.58% |
| 2012-12-31 | $5.53 M | -48.18% |
| 2011-12-31 | $10.68 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $167.55 B | 133,047.39% | 🇺🇸 USA |
 Pfizer PFE | $226.50 B | 179,885.54% | 🇺🇸 USA |
 Trevena TRVN | $45.13 M | -64.14% | 🇺🇸 USA |
 Recro Pharma
REPH | N/A | N/A | 🇺🇸 USA |
 Flexion Therapeutics
FLXN | N/A | N/A | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.36 B | 191.11% | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | $20.39 M | -83.79% | 🇺🇸 USA |